Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia

被引:52
|
作者
Leoutsakos, Jeannie-Marie S. [1 ]
Forrester, Sarah N. [1 ]
Lyketsos, Constantine. G. [1 ]
Smith, Gwenn S. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD 21224 USA
关键词
Alzheimer's disease; dementia; depression; latent class analysis; neuropsychiatric symptoms; QUALITY-OF-LIFE; ALZHEIMERS-DISEASE CENTERS; DATA SET UDS; INCIDENT DEMENTIA; CACHE COUNTY; RISK; PROGRESSION; PREVALENCE; PREDICTORS; INSTITUTIONALIZATION;
D O I
10.3233/JAD-150421
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: A number of studies have linked neuropsychiatric symptoms to increase risk of dementia. Objective: To determine if risk of conversion to mild cognitive impairment or dementia among healthy controls varied as a function of their pattern of neuropsychiatric symptoms. Method: We studied individuals in the National Alzheimer Coordinating Center dataset collected from 34 Alzheimer Disease Centers between 2005 and 2013. The analysis included 4,517 volunteers who were >= 60 years old, cognitively normal, and had complete Neuropsychiatric Inventory data at their baseline visit, and had at least one follow-up. We used latent class analysis to identify four classes based on patterns of NPI symptoms. We used a Cox proportional hazards model to determine if time to MCI or dementia varied by baseline latent class membership. Results: We identified four latent classes of neuropsychiatric symptoms: irritable, depressed, complex (depression, apathy, irritability, and nighttime behaviors) and asymptomatic. 873 participants converted to MCI or dementia. Hazard ratios for conversion by class were 1.76 (95% CI: 1.34, 2.33) for the irritable class, 3.20 (95% CI: 2.24, 4.58) for the complex class, and 1.90 (95% CI: 1.49, 2.43) for the depressed class, with the asymptomatic class as the reference. Conclusions: Membership in all three symptomatic classes was associated with greater risk of conversion to MCI or dementia; the complex class had the greatest risk. Different patterns of neuropsychiatric symptoms may represent different underlying neuropathological pathways to dementia. Further work imaging and pathology research is necessary to determine if this is the case.
引用
收藏
页码:483 / 493
页数:11
相关论文
共 50 条
  • [41] Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies
    Donaghy, Paul C.
    Taylor, John-Paul
    O'Brien, John T.
    Barnett, Nicola
    Olsen, Kirsty
    Colloby, Sean J.
    Lloyd, Jim
    Petrides, George
    McKeith, Ian G.
    Thomas, Alan J.
    PSYCHOLOGICAL MEDICINE, 2018, 48 (14) : 2384 - 2390
  • [42] Effect of COVID-19 quarantine on cognitive, functional and neuropsychiatric symptoms in patients with mild cognitive impairment and dementia
    Vernuccio, Laura
    Sara, Davide
    Inzerillo, Florenza
    Catanese, Giuseppina
    Catania, Angela
    Vesco, Miriam
    Cacioppo, Federica
    Dominguez, Ligia J.
    Veronese, Nicola
    Barbagallo, Mario
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (05) : 1187 - 1194
  • [43] Kynurenines, Neuropsychiatric Symptoms, and Cognitive Prognosis in Patients with Mild Dementia
    Soivang, Stein-Erik Hafstad
    Nordrehaug, Jan Erik
    Aarsland, Dag
    Lange, Johannes
    Ueland, Per Magne
    McCann, Adrian
    Midttun, Oivind
    Tell, Grethe S.
    Giil, Lasse Melvaer
    INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH, 2019, 12
  • [44] CLINICAL AND PROGNOSTIC SIGNIFICANCE OF NEUROPSYCHIATRIC SYMPTOMS IN MILD COGNITIVE IMPAIRMENT
    Mossello, E.
    Mello, A. M.
    Gullo, M.
    Ballini, E.
    Bencini, F.
    Caleri, V
    Tonon, E.
    Cantini, C.
    Simoni, D.
    Cavallini, M. C.
    Marini, M.
    Romani, M.
    Boncinelli, M.
    Tassinari, I
    Masotti, G.
    Biagini, C. A.
    Marchionni, N.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 21 (01) : 90 - 90
  • [45] Cerebrovascular Imaging Biomarkers, Neuropsychiatric Symptoms, and Mild Cognitive Impairment
    Vassilaki, Maria
    Syrjanen, Jeremy
    Scharf, Eugene
    Krell-Roesch, Janina
    Vemuri, Prashanthi
    Graff-Radford, Jonathan
    Mielke, Michelle
    Machulda, Mary M.
    Kremers, Walter
    Lowe, Val
    Jack, Clifford, Jr.
    Knopman, David
    Petersen, Ronald
    Geda, Yonas E.
    CIRCULATION, 2021, 144
  • [46] Development and Testing of a Neuropsychiatric Symptoms Model in Mild Cognitive Impairment
    Kirk, Laura
    Smith, Glenn E.
    Gaugler, Joseph E.
    Hepburn, Ken
    Knopman, David
    Lewis, Marsha
    JOURNAL OF GERONTOLOGICAL NURSING, 2018, 44 (01): : 21 - 30
  • [47] Frequency of neuropsychiatric symptoms in mild cognitive impairment and the impact in functionality
    Romo Guardado, Marcela
    Aguilar Salas, Ismael
    Ugalde, Oscar
    INTERNATIONAL PSYCHOGERIATRICS, 2015, 27 : S102 - S103
  • [48] Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease
    Siafarikas, N.
    Selbaek, G.
    Fladby, T.
    Benth, J. Saltyte
    Auning, E.
    Aarsland, D.
    INTERNATIONAL PSYCHOGERIATRICS, 2018, 30 (01) : 103 - 113
  • [49] Relationship between neuropsychiatric symptoms, cognition, and neuroimaging in mild cognitive impairment: Are we there yet? :Commentary on "Neuropsychiatric symptoms and their neural correlates in individuals with mild cognitive impairment"
    Velayudhan, Latha
    INTERNATIONAL PSYCHOGERIATRICS, 2023, 35 (11) : 595 - 597
  • [50] Neuropsychiatric symptoms and mortality among patients with mild cognitive impairment and dementia due to Alzheimer's disease
    Huang, Mei-Feng
    Lee, Wei-Ju
    Yeh, Yi-Chun
    Lin, Yung-Shuan
    Lin, Hsiu-Fen
    Wang, Shuu-Jiun
    Yang, Yi-Hsin
    Chen, Cheng-Sheng
    Fuh, Jong-Ling
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (09) : 1705 - 1713